![lee Giguere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
lee Giguere
No más puestos en curso
Fortuna: - $ al 31/07/2026
Perfil
lee G.
Giguere formerly worked at Boston Scientific Corp., as Senior Securities & Governance Counsel from 2013 to 2016, Chiasma, Inc., as Secretary, Vice President & General Counsel from 2019 to 2021, Karyopharm Therapeutics, Inc., as Deputy General Counsel from 2018 to 2019, Obsidian Therapeutics, Inc., as Secretary & Chief Legal Office from 2021 to 2024, Goodwin Procter LLP, as Head-Business Law Department from 2006 to 2013, and enGene Therapeutics, Inc., as Secretary & Chief Legal Officer from 2024 to 2026.
Dr. Giguere received his undergraduate degree from Northeastern University and graduate degree from Northeastern University School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/01/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Antiguos cargos conocidos de lee Giguere.
| Empresas | Cargo | Fin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Consejero General | 15/07/2026 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Consejero General | 01/01/2024 |
| CHIASMA, INC. | Consejero General | 05/08/2021 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2019 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/09/2016 |
Formación de lee Giguere.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
59
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Northeastern University School of Law
 Northeastern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Bolsa de valores
- Insiders
- lee Giguere
